NIPER Mohali Courses & Fees 2026

NIPER Mohali presents a comprehensive academic ecosystem for 2026 through its nationally benchmarked postgraduate and doctoral programs, covering MPharm, MS (Pharm), MTech, MBA (Pharm), and PhD across 20+ high-demand pharmaceutical science domains. With a total of 291 PG seats offered through 11 specialized MPharm/MS (Pharm) disciplines—ranging from Medicinal Chemistry (46 seats) and Pharmaceutics (36 seats) to Pharmacology & Toxicology, Natural Products, Biotechnology, and Pharmacoinformatics—the institute ensures rigorous merit-based entry exclusively via NIPER JEE, supported by minimum eligibility of 60% in BPharm or related degrees. The MBA (Pharm) program adds 42 seats in Pharmaceutical Management for CAT/GMAT/NIPER JEE candidates, while the MTech in Pharmaceutical Technology provides 9 research-oriented seats in Formulations and Process Chemistry.

At the doctoral level, NIPER Mohali expands its research footprint with 73 PhD seats across 12 disciplines, including Pharmaceutical Analysis, Regulatory Toxicology, Pharmacy Practice, Traditional Medicine, and advanced biotech-driven domains. Each program integrates structured research, mandatory thesis components, 70% lab-based learning, and interdisciplinary exposure through industry collaborations and national-level projects. Supported by NAAC A++ accreditation, a 135-acre research-focused campus, modern laboratories, and specialized centers in drug design, toxicology, and computational pharmaceutics, NIPER Mohali continues to set India’s highest benchmark as an Institute of National Importance—making it the foremost destination for pharma research, innovation, and leadership development.

NIPER Mohali’s M.Pharm programs for 2026 are structured around 8 industry-aligned and research-driven specializations, each functioning as an independent advanced course. Every specialization offers a 2-year full-time curriculum, admitting students through NIPER JEE, with eligibility set at 60% in B.Pharm (55% for reserved categories). These courses emphasize laboratory research, regulatory skills, and pharmaceutical innovation, supported by a uniform fee of ₹2,29,560.

NIPER Mohali’s MS (Pharm) programs for 2026 focus on three advanced specializations designed to build strong research, biotechnology, and informatics expertise. Each course is a 2-year full-time, lab-driven program offered through NIPER JEE/GPAT, with eligibility starting at 60% in B.Pharm, B.Tech, or M.Sc depending on the specialization. The total fee for all streams is ₹2,29,560, making these programs highly competitive and research-oriented.

NIPER Mohali’s MTech programs for 2026 offer two highly specialized 2-year tracks designed for pharmaceutical technology aspirants seeking advanced formulation and process-chemistry expertise. Admission is based on GATE/NIPER JEE, with a minimum of 60% in B.Pharm or B.Tech. With a total program fee of ₹2,04,000, these courses emphasize research-driven learning and industry-aligned technical skills.

NIPER Mohali’s MBA (Pharm) 2026 offers a focused 2-year specialization in Pharmaceutical Management, designed for graduates aiming for leadership, marketing, regulatory, and strategic roles in the pharma sector. Admissions are based on CAT/NIPER JEE, with a minimum of 60% in graduation. The program blends management principles with pharmaceutical industry insights at a total fee of ₹3,80,000.

NIPER Mohali offers a full-time PhD Programme across 12 advanced pharmaceutical specializations, admitting 73 scholars through NIPER JEE followed by an interview. The program spans 3–5 years, requires 60% in a relevant Master’s degree, and includes an annual fee of ₹88,550.